Follow The Filings

SXTP 60 Degrees Pharmaceuticals

60 Degrees Pharmaceuticals earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — -0.90 —
Rev — — —

Insider trades

Open-market buys and sales by SXTP's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SXTP insider trades
  • $30K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Geoffrey S Dow CEO
    Buy
    $10K 7,350 shares at $1.38 +44% to stake
    Traded Jun 12 Filed Jun 15
    ↗
  2. Geoffrey S Dow CEO
    Buy
    $7,759 9,670 shares at $0.8000 +19% to stake
    Traded Dec 15, 2025 Filed Dec 16, 2025
    ↗
  3. Geoffrey S Dow CEO
    Buy
    $12K 12,963 shares at $0.9400 +35% to stake
    Traded Dec 10–11 Filed Dec 12, 2025
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,3.02,8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 8.01 Filing Doc
DEF 14A DEFINITIVE PROXY STATEMENT Filing Doc
8-K 8.01 Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
10-K Filing Doc
8-K 8.01 Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 PROSPECTUS SUPPLEMENT Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 PROSPECTUS SUPPLEMENT Filing Doc
424B5 PROSPECTUS SUPPLEMENT Filing Doc

Source: SEC EDGAR submissions, updated about 8 hours ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.